A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan

PHASE3CompletedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

Duloxetine

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

651-0086

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hyōgo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shionogi

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT02248480 - A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan | Biotech Hunter | Biotech Hunter